Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection.
Uropathogenic Escherichia coli (UPEC) is the primary cause of uncomplicated urinary tract infections (UTIs). Whereas most infections are isolated cases, 1 in 40 women experience recurrent UTIs. The rise in antibiotic resistance has complicated the management of chronic UTIs and necessitates new preventative strategies. Currently, no UTI vaccines are approved for use in the United States, and the development of a highly effective vaccine remains elusive. Here, we have pursued a strategy for eliciting protective immunity by vaccinating with small molecules required for pathogenesis, rather than proteins or peptides. Small iron-chelating molecules called siderophores were selected as antigens to vaccinate against UTI for this vaccine strategy. These pathogen-associated stealth siderophores evade host immune defenses and enhance bacterial virulence. Previous animal studies revealed that vaccination with siderophore receptor proteins protects against UTI. The poor solubility of these integral outer-membrane proteins in aqueous solutions limits their practical utility. Because their cognate siderophores are water soluble, we hypothesized that these bacterial-derived small molecules are prime vaccine candidates. To test this hypothesis, we immunized mice with siderophores conjugated to an immunogenic carrier protein. The siderophore-protein conjugates elicited an adaptive immune response that targeted bacterial stealth siderophores and protected against UTI. Our study has identified additional antigens suitable for a multicomponent UTI vaccine and highlights the potential use of bacterial-derived small molecules as antigens in vaccine therapies.
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109.
Laura A
LA
Mike
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109.
Sara N
SN
Smith
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109.
Christopher A
CA
Sumner
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109.
Kathryn A
KA
Eaton
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109 hmobley@umich.edu.
Harry L T
HL
Mobley
D000818:Animals; D004927:Escherichia coli Infections / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D007249:Inflammation / Q000473:pathology; D051379:Mice; D017262:Siderophores / Q000276:immunology*; D014552:Urinary Tract Infections / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D056689:Uropathogenic Escherichia coli / Q000276:immunology*; D014611:Vaccination; D018074:Vaccines, Conjugate / Q000276:immunology*
D017262:Siderophores; D018074:Vaccines, Conjugate
UPEC; iron acquisition; siderophore; urinary tract infection; vaccine conjugate